Cardiovascular
Cardiovascular
-
Cardiovascular
BioCardia Issued Two New Patents
The patents pertain to technology that guides interventional therapies.Michael Barbella, Managing Editor 05.25.23
-
Cardiovascular | Patient Monitoring
Study Shows Abbott's CardioMEMS Sensor Almost Halves Heart Failure Hospitalizations
There was also significant improvement in patient-reported quality of life scores as early as three months after using the remote monitoring sensor.Sam Brusco, Associate Editor 05.24.23
-
Cardiovascular
Heart Rhythm 2023: Day Three Highlights
Society wraps up three-day conference with registry data presentations and more clinical trial news.Michael Barbella, Managing Editor 05.24.23
-
Cardiovascular
Heart Rhythm 2023: Studies Show Benefits of Left Bundle Branch Area Pacing
The results add to the growing body of evidence supporting new pacing methods.05.24.23
-
Cardiovascular
Heart Rhythm 2023: World's Smallest Leadless Pacemaker Shows Clinical Benefits
A leadless pacemaker can deliver cardiac resynchronization therapy to patients unable to be treated with conventional CRT and epicardial leads.Michael Barbella, Managing Editor 05.24.23
-
Cardiovascular
Heart Rhythm 2023: Latest Advances in Pulsed Field Ablation
New data from three late-breaking clinical trials supports pulsed field ablation as treatment option for atrial fibrillation.Michael Barbella, Managing Editor 05.24.23
-
Cardiovascular
Heart Rhythm 2023: Day Two Highlights
Results from a dozen clinical studies were presented and discussed.Michael Barbella, Managing Editor 05.23.23
-
Cardiovascular
Heart Rhythm 2023: Cardiac Physiological Pacing Guideline Released
New guidance covers recommendations on pacing device indications, pre/during/post implant evaluations.Michael Barbella, Managing Editor 05.23.23
-
Cardiovascular
Heart Rhythm 2023: Noninvasive Ear-Clip Therapy Treats Postural Tachycardia Syndrome
Treatment offers non-pharmacological approach for treating common blood circulation disorder.Michael Barbella, Managing Editor 05.23.23
-
Cardiovascular
Heart Rhythm 2023: Strides Made Toward Balanced Sex, Racial Representation in Clinical Studies
BIO-LIBRA trial enrolled 48% women and 30% non-white patients with non-ischemic cardiomyopathy treated with implanted defibrillators.Michael Barbella, Managing Editor 05.23.23
-
Cardiovascular | Patient Monitoring
Biotronik Introduces BIOMONITOR IV Implantable Cardiac Monitor
The company's first ICM with SmartECG, an intelligent system with advanced algorithms, receives FDA approval.Sam Brusco, Associate Editor 05.23.23
-
Cardiovascular | Surgical
Reflow Medical's coraCatheters Line Gains FDA Nod
The release expands Reflow into complex percutaneous coronary interventions.Sam Brusco, Associate Editor 05.23.23
-
Cardiovascular
Study Supports Medtronic's Extravascular ICD
The device is implanted below the left armpit in a minimally invasive approach.Sam Brusco, Associate Editor 05.23.23
-
Cardiovascular
Study Backs Abbott's Dual-Chamber, Leadless Pacemaker
Over 97% of participants achieved successful atrio-ventricular (AV) synchrony.Sam Brusco, Associate Editor 05.23.23
-
Cardiovascular
Heart Rhythm 2023: Highlights From Day One
Annual event focuses on cardiac science and innovation.Michael Barbella, Managing Editor 05.22.23
-
Cardiovascular
Heart Rhythm 2023: Consensus Statement on Arrhythmia Management During Pregnancy Released
The consensus statement is a result of an international collaboration between recognized experts across various fields of study.Michael Barbella, Managing Editor 05.22.23
-
Cardiovascular | Digital Health
Heart Rhythm 2023: AI Accurately Predicts Near-Term Ventricular Arrhythmias
Results show model correctly identified ventricular arrhythmias in 88% of patients with sustained ventricular tachycardia.Michael Barbella, Managing Editor 05.22.23
-
Cardiovascular
Heart Rhythm 2023: Weight Loss Before Afib Ablation Improves Outcomes Among Obese Patients
Study identifies weight loss before undergoing an ablation procedure as a risk-factor reduction tool for AF patients.Michael Barbella, Managing Editor 05.22.23
-
Cardiovascular | Patient Monitoring
Abbott, Stereotaxis to Combine Heart Mapping and Robotic Technologies
The two companies aim to improve treatment of abnormal heart rhythms.Sam Brusco, Associate Editor 05.19.23
-
Cardiovascular | Surgical
FDA Approves Abbott's TactiFlex Ablation Catheter for Abnormal Heart Rhythm
According to Abbott, it’s the world’s first ablation catheter with flexible tip and contact force technology.Sam Brusco, Associate Editor 05.19.23
